Cancer Clinical Trial -DynamiCure Biotechnology-DC-6001-101

DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Drug

DCBY02

Phase

Phase I

Condition

Breast, Cervical, Colorectal, Gastric, Globlstoma, Head and Neck, Hepatocellular, Non- Small Cell Lung, Ovarian, Renal

Keywords

CD93